Product Program year 2025 Source: CMS Open Payments

Vercise

Device Vercise_NMD

PDI 08714729965848

Open in the dashboard

General payments

$2,877,689

5,021 payments

Research payments

$1,539,708

368 payments

Through program year 2025, $2,877,689 in general payments and $1,539,708 in research payments were reported against Vercise (Vercise_NMD).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $953,539 1,373
2025 Research $735,009 166
2024 General $1,001,769 1,562
2024 Research $777,579 195
2023 General $689,124 977
2023 Research $27,120 7
2022 General $233,257 1,109

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $2,877,689 5,021 payments
Top recipients General payments · program year 2025
  1. Danielle Englert Doggett Neurology · Charlotte, NC $45,946 5% · 54 payments
  2. Mustafa Siddiqui Neurology · Winston Salem, NC $38,361 4% · 51 payments
  3. Doris Wang San Francisco, CA $36,142 4% · 5 payments
  4. Corneliu Luca Neurology · Miami, FL $32,732 3% · 15 payments
  5. Helen Shi Neurological Surgery · Portland, OR $25,000 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $488,539 59% · 197 practitioners
  2. Neurological Surgery $227,870 28% · 56 practitioners
  3. Physician Assistant $30,107 4% · 26 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $23,443 3% · 33 practitioners
  5. Nurse Practitioner $18,094 2% · 24 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $189,507 20% · 58 recipients
  2. Florida $99,989 10% · 60 recipients
  3. North Carolina $95,994 10% · 12 recipients
  4. Pennsylvania $81,364 9% · 20 recipients
  5. Oregon $66,905 7% · 9 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,021 general · 368 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record